Consumer & Prescriber Grant Program

The Consumer & Prescriber Grant Program (also going by other names, including Attorney General Prescriber Grant Program) was a grant program established with fines paid by Pfizer in the Franklin v. Parke-Davis trial for False Claims Act violations relating to off-label use of gabapentin.[1][2]

Grant recipients

There were 24 original grant recipients.

gollark: Rust's really nice but I don't actually want to care about lifetimes all the time, and the compiler is slow. Python is very fast for me to prototype with but not very robust. JS is the same but slightly worse, and I only use it because web platform. ML-family things could be cool but have bad tooling and libraries.
gollark: I dislike all programming languages to varying degrees while still using them.
gollark: At least it has generics now, after several years of it not having them and people claiming they weren't needed.
gollark: The best way to describe the problem is probably that it's just generally very hostile to abstraction.
gollark: I resent it somewhat, because while Go has very cool *libraries* and such, and the tooling at least seems to work nicely even if it's somewhat insane, the language is really unpleasant.

References
  1. Rutkow, Lainie; Teret, Stephen (October 2010). "The Potential for State Attorneys General to Promote the Public's Health: Theory, Evidence, and Practice". Robert Wood Johnson Foundation Public Health Law Research Program, via FOLIO.
  2. Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
  3. "Attorney Generals' Prescriber and Consumer Education Grant". College of Pharmacy. 4 October 2011.
  4. Price, DW; Raebel, MA; Conner, DA; Wright, LA (2008). "Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs". The Permanente Journal. 12 (2): 28–35. doi:10.7812/tpp/07-106. PMC 3042287. PMID 21364809.
  5. Elliott, Carl (22 May 2012). "Pharmed Out: an Interview With Adriane Fugh-Berman". The Chronicle of Higher Education Blogs: Brainstorm.
  6. "Federation of State Medical Boards". www.fsmb.org. Archived from the original on 2016-05-20. Retrieved 2017-06-21.
  7. Vermont, University of (14 April 2006). "University Communications : University of Vermont". www.uvm.edu.
  8. Nachbur, Jennifer (May 21, 2013). "Advancing Integrity in Medical Education". www.pewtrusts.org. The Pew Charitable Trusts.
  9. Krautkramer, Christian J. (June 2006). "Neurontin and off-label marketing". AMA Journal of Ethics. 8 (6): 397–402. doi:10.1001/virtualmentor.2006.8.6.hlaw1-0606. PMID 23234671.
  • Official website archival copy from March 2011. The website existed from 2008-2011.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.